4.05
Finanzdaten der Opus Genetics Inc-Aktie (IRD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
65.00%
0.755
|
2.157 | 3.865 | 3.079 | 2.882 |
| Operating Expenses |
4.32%
17.23
|
16.52 | 15.32 | 11.39 | 11.79 |
| Operating Income/Loss |
14.73%
-16.48
|
-14.36 | -11.45 | -8.311 | -8.906 |
| Income/Loss From Continuing Operations Before Tax |
87.64%
-8.098
|
-65.53 | -16.52 | -17.45 | -7.42 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
87.64%
-8.098
|
-65.53 | -16.52 | -17.45 | -7.42 |
| Basic Average Shares |
9.89%
95.48
|
86.89 | - | 70.64 | 63.38 |
| Diluted Average Shares |
28.19%
111.38
|
86.89 | - | 70.64 | 63.38 |
| Basic Earnings Per Share |
89.33%
-0.08
|
-0.75 | - | -0.25 | -0.12 |
| Diluted Earnings Per Share |
81.33%
-0.14
|
-0.75 | - | -0.25 | -0.12 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):